Form D · Other Health Care

NeuTrace, Inc.

Longwood, FL · CIK 0001823116

Offering snapshot reported Aug 22, 2022 · SEC filing

Reported sold
$2.5M
Offering amount: $2.5M
Investors reported
9
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Aug 12, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 22, 2022Initial$2,500,000No comparison9SEC filing
Jun 15, 2021Initial$4,799,999No comparison74SEC filing
Sep 15, 2020Initial$2,500,000No comparison53SEC filing

Offering details

Securities
Debt, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-456518
Convertible promissory note, and common stock issuable upon conversion of such note.

Source: Form D, filed Aug 22, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Heinmiller Director
Srijoy Mahapatra Executive
Raghuveer Mendu Director, Executive
Nalluru Murthy Director, Executive
Kalyanam Shivkumar Director
Roy Tanaka Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
390 Vista Oak Drive
Longwood, FL, 32779